![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lack of Drug Interactions Between Boosted and Unboosted
TAF-Based Antiretroviral Single-Tablet Regimens
(E/C/F/TAF, R/F/TAF) and the anti-HCV
Single-Tablet Regimen Ledipasvir/Sofosbuvir
|
|
|
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
Joseph M. Custodio, Eileen B. Doyle, Phillip S. Pang, Moupali Das,
Huyen Cao, Grace Ma, Anita Mathias, Julia Zack
Gilead Sciences, Inc., Foster, City, CA
![IDSA1.gif](../images/101315/101315-3/IDSA1.gif)
![IDSA2.gif](../images/101315/101315-3/IDSA2.gif)
![IDSA3.gif](../images/101315/101315-3/IDSA3.gif)
![IDSA4.gif](../images/101315/101315-3/IDSA4.gif)
![IDSA5.gif](../images/101315/101315-3/IDSA5.gif)
![IDSA6.gif](../images/101315/101315-3/IDSA6.gif)
![IDSA7.gif](../images/101315/101315-3/IDSA7.gif)
![IDSA8.gif](../images/101315/101315-3/IDSA8.gif)
![IDSA9.gif](../images/101315/101315-3/IDSA9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|